UFC newcomer Jorge Gonzalez has yet to make it to the octagon, and he’ll be waiting a fair bit longer before he does. On Friday, a press release by USADA (U.S. Anti-Doping Agency) officials announced that Mexico’s Gonzalez (16-4) had been hit with a lengthy suspension, to the tune of two years on the sidelines.
That’s after Gonzalez tested positive for multiple banned substances in an out-of-competition drug test administered in August.
Per Friday’s release, Gonzalez “tested positive for stanozolol metabolites 16β-hydroxystanozolol and 4β-hydroxystanozolol, drostanolone metabolite 2α-methyl-5α-androstan-3α-ol-17-one, and tamoxifen metabolite 3-hydroxy-4-methoxytamoxifen as the result of a urine sample collected out-of-competition on August 5, 2020.”
Both Stanozolol and Drostanolone are anabolic agents, banned at all times under the UFC’s anti-doping policy.
USADA went on to note that as a new UFC fighter, Gonzalez had been afforded the opportunity to declare all medications and supplements used in the previous 12 months, without fear of sanction. However, Gonzalez did not declare any of the substances he later tested positive for.
“St. George” was originally scheduled to face Kenneth Bergh in July, only for Bergh to drop out of the fight. He was then booked against Ike Villanueva at UFC 252 in August. That fight was pushed back a week, only for Gonzalez to drop out of the affair.
Gonzalez’s suspension will be backdated to the date his positive sample was collected in August, meaning he won’t be back until 2022.
